AcquisitionOther
Apimeds Pharmaceuticals US, Inc. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Apimeds Pharmaceuticals US, Inc. -> target · $100M
The combined company integrates high-growth biotechnology and institutional digital-treasury capabilities, with the merger supported by a simultaneous PIPE of up to $100 million to advance Apimeds' clinical programs and expand MindWave's digital asset infrastr
Open source record (SEC) ↗